LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

Search

Waters Corp

Slēgts

SektorsVeselības aprūpe

359.3 2.35

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

345.57

Max

359.3

Galvenie mērījumi

By Trading Economics

Ienākumi

-110M

121M

Pārdošana

-211M

662M

P/E

Sektora vidējais

33.303

56.602

EPS

2.25

Peļņas marža

18.344

Darbinieki

7,600

EBITDA

-193M

152M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt

Prognoze 12 mēnešiem

+12.83% upside

Dividendes

By Dow Jones

Nākamie ieņēmumi

2025. g. 30. jūl.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

-499M

22B

Iepriekšējā atvēršanas cena

356.95

Iepriekšējā slēgšanas cena

359.3

Ziņu noskaņojums

By Acuity

26%

74%

65 / 382 Rangs Healthcare

Tehniskais rādītājs

By Trading Central

Pārliecība

Strong Bullish Evidence

Waters Corp Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 16. maijs 19:39 UTC

Galvenie tirgus virzītāji

UroGen Falls to 52-Week Low, FDA Document Indicates Cancer Drug Study Disagreement

2025. g. 16. maijs 23:18 UTC

Top Ziņas

U.S. Loses Last Triple-A Credit Rating -- 2nd Update

2025. g. 16. maijs 22:30 UTC

Top Ziņas

U.S. Loses Last Triple-A Credit Rating -- Update

2025. g. 16. maijs 21:56 UTC

Tirgus saruna

Fitch Raises Greece's Outlook to Positive From Stable -- Market Talk

2025. g. 16. maijs 21:56 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 16. maijs 21:54 UTC

Top Ziņas

U.S. Loses Last Triple-A Credit Rating -- WSJ

2025. g. 16. maijs 21:22 UTC

Tirgus saruna

Moody's Says U.S. Fiscal Performance Likely to Deteriorate -- Market Talk

2025. g. 16. maijs 21:17 UTC

Tirgus saruna

Treasury Yields Rise, Dollar Falls After Moody's Cuts U.S. Credit Rating -- Market Talk

2025. g. 16. maijs 21:17 UTC

Top Ziņas

The Score: UnitedHealth, Walmart, Coinbase Global and More Stocks That Moved on the Week's News -- WSJ

2025. g. 16. maijs 21:05 UTC

Tirgus saruna

Moody's Downgrades U.S. Credit Rating Due to Deficit, Debts -- Market Talk

2025. g. 16. maijs 20:55 UTC

Iegādes, apvienošanās, pārņemšana

What's Next for Cable Giant Comcast After Charter-Cox Merger -- Barrons.com

2025. g. 16. maijs 20:50 UTC

Tirgus saruna
Peļņas

Financial Services Roundup: Market Talk

2025. g. 16. maijs 20:50 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2025. g. 16. maijs 20:37 UTC

Top Ziņas

Trade Progress Sparks Bullish Week for Wall Street -- WSJ

2025. g. 16. maijs 20:33 UTC

Tirgus saruna
Iegādes, apvienošanās, pārņemšana

Dick's-Foot Locker Deal Looks Like a Bet on Nike's Turnaround -- Market Talk

2025. g. 16. maijs 20:30 UTC

Iegādes, apvienošanās, pārņemšana

Galaxy Digital Begins U.S. Trading as Bitcoin Keeps Powering Ahead -- Barrons.com

2025. g. 16. maijs 20:18 UTC

Top Ziņas

Major U.S. Stock Indexes Rise; U.S. Running Out of Patience for Trade Deals -- WSJ

2025. g. 16. maijs 20:16 UTC

Top Ziņas

Justice Department Wants to Spare Boeing From Guilty Plea Over 737 MAX Charges -- 3rd Update

2025. g. 16. maijs 20:15 UTC

Peļņas

Tesla Stock Rises. Even Hedge Fund Sales Can't Keep It Down. -- Barrons.com

2025. g. 16. maijs 20:11 UTC

Iegādes, apvienošanās, pārņemšana

Henry Schein: William K. Daniel Joins Board

2025. g. 16. maijs 20:10 UTC

Iegādes, apvienošanās, pārņemšana

Henry Schein: Strategic Investment by KKR Completed

2025. g. 16. maijs 20:05 UTC

Iegādes, apvienošanās, pārņemšana

What's Next for Cable Giant Comcast After Charter-Cox Merger -- Barrons.com

2025. g. 16. maijs 19:38 UTC

Tirgus saruna

Oil Futures Post Second Straight Weekly Gain -- Market Talk

2025. g. 16. maijs 19:07 UTC

Tirgus saruna

U.S. Natural Gas Futures End Week Lower -- Market Talk

2025. g. 16. maijs 18:51 UTC

Top Ziņas

Early Read on Consumer Sentiment Falls to Second Lowest on Record -- 5th Update

2025. g. 16. maijs 18:41 UTC

Iegādes, apvienošanās, pārņemšana

What's Next for Cable Giant Comcast After Charter-Cox Merger -- Barrons.com

2025. g. 16. maijs 18:37 UTC

Tirgus saruna

Gold Futures End Week on Negative Note -- Market Talk

2025. g. 16. maijs 18:35 UTC

Top Ziņas

Ozempic Drugmaker's CEO Pushed Out Amid Weight-Loss Market Challenges -- 3rd Update

2025. g. 16. maijs 18:32 UTC

Top Ziņas

Trump Floats Plan to Impose New Tariff Rates; Stocks Hold Steady -- WSJ

2025. g. 16. maijs 18:28 UTC

Tirgus saruna

Weaker Dollar Seen as Helping Some Business to Avoid Price Increases -- Market Talk

Salīdzinājums

Cenas izmaiņa

Waters Corp Prognoze

Cenas mērķis

By TipRanks

12.83% augšup

Prognoze 12 mēnešiem

Vidējais 396.71 USD  12.83%

Augstākais 460 USD

Zemākais 350 USD

Pamatojoties uz 14 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Waters Corp — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

14 ratings

7

Pirkt

7

Turēt

0

Pārdot

Tehniskais rādītājs

By Trading Central

345.22 / 351.01Atbalsts un pretestība

Īstermiņā

Strong Bullish Evidence

Vidējā termiņā

Bearish Evidence

Ilgtermiņā

Bearish Evidence

Noskaņojums

By Acuity

65 / 382 Rangs Veselības aprūpe

Ziņu noskaņojums

Liecība "Buļļu" tendencei

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Virs vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Waters Corp

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Further, the company provides thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.